IRI: 15% of consumers looking to increase purchase of premium-positioned natural, organic products in next year
McKesson extends pharmaceutical distribution deal with CVS Caremark
SAN FRANCISCO — McKesson announced on Wednesday a three-year extension of its existing distribution agreement with CVS Caremark through June 2019.
“We have a long track record of delivering comprehensive supply chain solutions to CVS Caremark which in turn allows CVS Caremark to ensure the highest level of pharmaceutical care to its customers,” stated Paul Julian, EVP, group president, McKesson. “We are pleased to have extended our agreement with CVS Caremark and continue our long standing partnership.”
Tanzeum now available in U.S. pharmacies
PHILADELPHIA — GSK announced that Tanzeum (albiglutide), a once-weekly, prescription injectable treatment for Type 2 diabetes in adults, is now available in pharmacies throughout the United States.
Tanzeum was approved by the Food and Drug Administration on April 15, 2014 as an adjunct to diet and exercise to improve glycemic control. The drug is not recommended as first-line therapy for patients inadequately controlled on diet and exercise, according to GSK.
"With approximately 21 million adults diagnosed with diabetes in the US1, and up to 95 percent of those patients living with type 2 diabetes, we're excited that for the appropriate patients Tanzeum is now available as a treatment option for healthcare professionals," said Cheryl MacDiarmid, vice president of GSK's general medicine business.